Method for preparing microspheres through oil in nano-particle suspension and sustained-release microspheres
A nanoparticle and suspension technology, applied in the direction of freeze-drying delivery, powder delivery, drug combination, etc., can solve the problems of local microencapsulation and inflammation that cannot overcome the encapsulation rate, so as to reduce inflammation and microencapsulation, enhance The effect of cell adhesion
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Example 1 Preparation of doxorubicin polylactic-glycolic acid (PLGA) microspheres with antibacterial and anticancer effects
[0054] (1) Dissolve 20mg of doxorubicin in 0.5ml of dimethyl sulfoxide (DMSO);
[0055] (2) Sonicate the above drug solution and PLGA dichloromethane solution with a percentage concentration of 0.1% at a weight ratio of 1:9 for 1-5 minutes to form a uniform liquid;
[0056] (3) Add the liquid obtained in step (2) dropwise to the suspension of titanium dioxide nanoparticles with a concentration of 1% by weight or the suspension of nanoparticles and PVA surfactant with a concentration of 20% by weight and stir, Vortex or sonicate for 0.1-5 minutes to form double emulsion (O / S) emulsion;
[0057] (4) Add the double emulsion of step (3) dropwise to 1000ml sodium chloride solution with a concentration of 5% (w / w) and solidify for 2 hours;
[0058] (5) The microspheres obtained in the step (4) are collected by centrifugation, washed with water for 3-...
Embodiment 2
[0060] Example 2 Preparation of Exenatide Polylactic-Glycolic Acid (PLGA) Microspheres
[0061] (1) 20 mg and 10 mg of polyethylene glycol (PEG molecular weight 8000) exenatide dissolved in 0.5 ml of dimethyl sulfoxide (DMSO);
[0062] (2) Sonicate the above drug solution and PLGA dichloromethane solutions of different molecular weights and models with a weight ratio of 1:9 for 1-5 minutes to form a uniform liquid;
[0063] (3) Add the emulsion obtained in step (2) dropwise to the suspension of hydroxyapatite nanoparticles with a concentration of 60% by weight or the suspension of nanoparticles and PVA surfactant with a concentration of 30% by weight And stir, vortex or sonicate for 0.1-5 minutes to form (O / S) emulsion;
[0064] (4) Add the double emulsion of step (3) dropwise to 1000ml sodium chloride solution with a concentration of 5% (w / w) and solidify for 2 hours;
[0065] (5) The microspheres obtained in the step (4) are collected by centrifugation, washed with water f...
Embodiment 3
[0067] Example 3 Preparation of octreotide polylactic-glycolic acid (PLGA) microspheres
[0068] (1) 20mg octreotide dissolved in 0.5ml dimethyl sulfoxide (DMSO) solution;
[0069] (2) Sonicate the above drug solution and PLGA dichloromethane solution with a percentage concentration of 20% in a weight ratio of 1:9 for 1-5 minutes to form a uniform liquid;
[0070] (3) Add the liquid obtained in step (2) dropwise to the suspension of hydroxyapatite nanoparticles with a concentration of 80% by weight or the suspension of nanoparticles and PVA surfactant with a concentration of 50% by weight And stir, vortex or sonicate for 0.1-5 minutes to form (O / S) emulsion;
[0071] (4) Add the double emulsion of step (3) dropwise to 1000ml sodium chloride solution with a concentration of 5% (w / w) and solidify for 2 hours;
[0072] (5) The microspheres obtained in the step (4) are collected by centrifugation, washed with water for 3-5 times, and freeze-dried to obtain the microspheres.
[...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 